ROYAL BANK OF CANADA
BankPosition in CRL — Charles River Laboratories International, Inc.
CIK 1000275
TORONTO, A6
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,303,646
-$7,363,249 QoQ
Shares Held
100,311
-18.9% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.85123266640747.ToString("F0")%
Shared 6.837734645253263.ToString("F0")%
None 0.3110326883392649.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Derivatives in CRL
reported options exposure · as of Dec 31, 2020CallValue
$2,848,404
CallShares
11,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $3,593,465,193 across 39 Diagnostics & Research names. CRL ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,913,903 | $1,923,800,734 | |
| 2 | DHR |
Danaher Corp /De/
|
3,299,528 | $625,590,502 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
391,704 | $220,094,556 | |
| 4 | LH |
Labcorp Holdings Inc.
|
820,442 | $218,902,126 | |
| 5 | A |
Agilent Technologies, Inc.
|
828,773 | $94,463,542 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
401,428 | $68,459,527 | |
| 7 | WAT |
Waters Corp /De/
|
228,857 | $68,153,609 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
123,929 | $59,509,461 |
All Filings in CRL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,303,646 | 100,311 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,666,895 | 123,656 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $41,918,759 | 267,920 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $44,430,484 | 292,826 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $94,482,904 | 627,710 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $28,632,196 | 155,104 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $32,853,606 | 166,795 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $36,285,566 | 175,649 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $46,963,218 | 173,328 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $43,403,981 | 183,604 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $37,094,305 | 189,276 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $39,590,911 | 188,304 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $34,008,278 | 168,508 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,252,179 | 170,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $35,797,130 | 181,896 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $163,967,989 | 766,313 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $220,570,570 | 776,739 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $273,391,562 | 725,600 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $296,832,288 | 719,297 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,904,989 | 732,334 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $208,603,688 | 719,745 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $2,848,404 | 11,400 | Call | Defined | 2021-02-16 | |
| 2020-12-31 | $171,112,117 | 684,832 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $152,109,858 | 671,715 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $100,014,130 | 573,640 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $67,867,909 | 537,738 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||